Lara Goldstein - Spark Newswire

2 minute read

COMPASS Pathways Shares Q3 2022 Financial Results, Business News & Term’s Highlights

Today, 5:10 PM

Psychedelics mental healthcare firm COMPASS Pathways (NASDAQ: CMPS) reported its financial outcomes for the third quarter ended 30 September 2022 and gave an update on its most recent pipeline and business developments.

CMPS

2 minute read

LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress

By Lara Goldstein

Today, 5:10 PM

Holding company Blackhawk Growth Corp.(OTC: BLRZF)'s subsidiary company MindBio Therapeutics Pty Ltd shared the positive data gathered from its

BLRZF

2 minute read

Oregon’s Jackson County Hosts Hearing On Amendments For Psilocybin Services Centers, ‘Opt-Out’ Vote

By Lara Goldstein

Today, 5:10 PM

“Never a dull moment in the psychedelics space,” says Silo Wellness (OTCQB: SILFF) founder and CEO Mike Arnold.

SILFF

2 minute read

Legal Mushroom Products From Amanita Muscaria Shipped To 37 US States

By Lara Goldstein

Today, 5:10 PM

Canadian-based producer of mushroom-derived health supplements Psyched Wellness Ltd.

PSYCF

2 minute read

Florida’s Growing Psychedelic Treatment Options: Healthcare Company Expands Network Of Clinics

By Lara Goldstein

Today, 5:10 PM

Senior health brand Irwin Naturals Inc.

IWINF

3 minute read

Psychedelic Therapy Frontiers Podcast Is Back, Check Out Upcoming Episodes

By Lara Goldstein

Today, 5:10 PM

Mental health care company Numinus Wellness (OTCQX: NUMIF) is re-launching its "Psychedelic Therapy Frontiers" podcast series dedicated to exploring the psychedelics renaissance and cultivating mind, body and spiritual health with new hosts, expanded topics and fr

NUMIF

3 minute read

Ketamine Therapy: Revitalist’s New Financing Option, Irwin Naturals Expands Chain Of Clinics

By Lara Goldstein

Today, 5:10 PM

Revitalist Increases Patient Access By Financing Costs With M-Lend Financial

IWINF

4 minute read

Psyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant’s LSD Therapy & More

By Lara Goldstein

Today, 5:10 PM

15 Global Psychedelics Executives To Keep An Eye On In 2022

KONEF

5 minute read

EXCLUSIVE: Insider’s Peek At Mammoth Of Psychedelics VCs, Palo Santo’s Investment Fundamentals & Specificities

By Lara Goldstein

Today, 5:10 PM

(Part one of a four-part series)

ATAI

4 minute read

Australian Psychedelics: Incannex Business & Financials, New Research Center For Mushrooms & Eating Disorders

By Lara Goldstein

Today, 5:10 PM

Clinical-stage biopharma company Incannex Healthcare Ltd. (NASDAQ: IXHL) shared its quarterly activities report and appendix 4C for the period ended 30 September 2022, noticeably applying for several U.S.

IXHL